Brazil

Fri
03
Sep

Cannabis firms catch a whiff of opportunity in Brazil

man holding Brazil flag at soccer game

 International cannabis companies are showing interest in Brazil, both its large consumer market for medicinal products and a proposal that could legalize planting of the crop.

Major producers like Colombia’s Clever Leaves and Canada’s Canopy Growth are developing and selling medicinal cannabis products to a Brazilian consumer segment estimated at 10 to 13 million people. This results from a 2019 regulatory change allowing the import, sale and manufacturing of such products.

But permission for cultivation of hemp and cannabis in Brazil would be a bigger prize. If granted, the industry could blossom in four to five years, based on the experience of other countries such as Colombia.

Fri
20
Aug

Cannabis firms catch a whiff of opportunity in Brazil

marijuana plants

SAO PAULO (Reuters) – International cannabis companies are showing interest in Brazil, both its large consumer market for medicinal products and a proposal that could legalize planting of the crop.

Major producers like Colombia’s Clever Leaves and Canada’s Canopy Growth are developing and selling medicinal cannabis products to a Brazilian consumer segment estimated at 10 million to 13 million people. This results from a 2019 regulatory change allowing the import, sale and manufacturing of such products.

But permission for cultivation of hemp and cannabis in Brazil would be a bigger prize. If granted, the industry could blossom in four to five years, based on the experience of other countries such as Colombia.

Wed
18
Aug

MediPharm Labs Receives Export Authorization to Ship Medical Cannabis to Brazil

landscape image of brazil

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company that specializes in cannabis, is pleased to announce that it has received approval to ship medical cannabis oil to Brazil. This approval, issued by both ANVISA and Health Canada, allows initial shipments to patients for the Company’s partner XLR8. The shipment is a crucial milestone for the Company in using its pharmaceutical Good Manufacturing Practices (“GMP”) platform for international manufacturing and distribution.

Fri
11
Jun

Brazil Moves Toward Cannabis Legalization

It is unclear if the upper house will approve the law or not. What is clear, however, is that the Bolsonaro administration adamantly opposes any kind of use of cannabis.

On Tuesday, June 8, the Brazilian Chamber of Deputies’ Special Commission very narrowly approved a bill authorizing cannabis cultivation for medicinal, veterinary, scientific, and industrial use.

Government supporters tried their best to prevent the legislation from heading to the upper house for final approval, but Deputy Luciano Ducci’s crucial vote ensured the bill survived.

Tue
22
Sep

Paraguay Grows it, Brazil Takes it… Will New Cannabis Laws Change Anything?

South America is becoming a new hotspot for changing cannabis laws, and international cannabis trading. One of the biggest providers of cannabis in South America is Paraguay, with much of its product being moved to Brazil. But it’s all black-market. Can the new rules change this?

Paraguay is a landlocked country in South America which is bordered by Brazil, Argentina, and Bolivia. While it has suffered a significant amount of civil unrest and wars, the country has been democratizing since the late 1900s. This too, has come with years of military instability, political assassinations, and other corruption.

Tue
30
Jun

Marijuana use increased during COVID-19 lockdown, survey shows

The coronavirus pandemic led to a decrease in the use of party drugs like MDMA and cocaine, but also to an increase in pot use, according to Global Drug Survey.

Forty thousand people from 12 countries participated in the online survey that looked at changes in alcohol and drug-related habits during the global health crisis. The 12 countries included in the study were Germany, France, the Netherlands, New Zealand, Ireland, Australia, the United Kingdom, Austria, Denmark, Greece, Brazil, and Switzerland. 

Based on the data, nearly a fifth of people reported that they used less cocaine during lockdown, while 29% said they used less MDMA, popularly known as ecstasy or molly. 

Fri
24
Apr

Brazil Issues Its First Authorization For The Manufacturing Of A Cannabis-Based Product

On Wednesday, Brazil announced in its DOU (Federal Official Gazette), that ANVISA, Brazil's National Health Surveillance Agency,  will allow the manufacturing and marketing of the first cannabis-containing phytopharmaceutical product, with up to 0.2% of THC content.

While ANVISA had approved the creation of a new classification for cannabis products in December, the law only took effect on March 10. And, it was only this Wednesday that the DOU (Federal Official Gazette) disclosed the first manufacturing and marketing permit.

The new proposal speeds up the manufacturing and marketing of cannabis products. Prior to this measure, their import could take a long time, with a high expense for patients.

Tue
24
Dec

Should cannabis be allowed in Brazil to cheapen medicines?

Brazilians will soon be able to buy in drugstores products derived from cannabinoids required by physicians. But, how much will they cost? Will they be affordable for everyone? According to specialists, the answer is no if national cultivation of cannabis is not equally allowed.

Let’s go back to the beginning: the discussions about cannabinoids medicines in Brazil has been long, full of prejudice and conservatism — like unsustained fear of encouraging recreational use, while marijuana is already the most used illicit drug in Brazil, according to Oswaldo Cruz Foundation (Fiocruz).

Thu
12
Dec

New guidelines approved for medical cannabis in Brazil

This week Brazil approved cannabis guidelines in order to establish a legalised environment for the sale and consumption of cannabis for medical use.

Thu
05
Dec

Brazil finally has medical marijuana regulations in place

After several delays, Brazil finally has regulations for launching medical marijuana sales this week.

Brazil’s national health surveillance agency, the Anvisa (Agência Nacional de Vigilância Sanitária), approved regulations for launching medical marijuana sales in the country, with the new rules set to take effect within the next 90 days.

The new regulation allows sales of products with THC levels above 0.2% to terminally-ill patients or those who lack alternative treatment options. Other patients will have access to medical marijuana products with THC levels below 0.2%.

The decision is a small step forward in the country whose right-wing President Jair Bolsonaro is compared to US President Donald Trump.

Pages

Subscribe to RSS - Brazil